InvestorsHub Logo
Followers 45
Posts 428
Boards Moderated 0
Alias Born 03/04/2011

Re: None

Wednesday, 08/29/2012 11:49:23 AM

Wednesday, August 29, 2012 11:49:23 AM

Post# of 346071
For those of you looking for new potential pipeline buyers for
PPHM:

BY JEANNE WHALEN AND MARTA FALCONI
U.K. drug maker AstraZeneca PLC appointed Pascal Soriot from Swiss rival Roche Holding AG as chief executive, in the hope that his science background and years at one of the industry?s most successful drug developers can help change AstraZeneca?s fortunes.

Dr. Soriot, a veterinarian by training, has been chief operating officer at Roche?s pharmaceutical division since 2010. The 53-year-old Frenchman also briefly served as CEO of Genentech after Roche acquired full control of the California biotech company in 2009. He starts at AstraZeneca on Oct. 1.

AstraZeneca has suffered a number of expensive drug-development failures in recent years and shown ..."

IMO this is a guy who is going to be aggressive about filling his pipeline and who knows Garnick well.

Best Regards,
RRdog
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News